X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (426) 426
humans (417) 417
leukemia, myeloid, acute - genetics (308) 308
hematology (302) 302
npm1 (302) 302
acute myeloid leukemia (267) 267
mutation (259) 259
nuclear proteins - genetics (258) 258
female (245) 245
male (231) 231
oncology (225) 225
middle aged (218) 218
adult (204) 204
acute myelogenous leukemia (200) 200
aml (200) 200
prognosis (200) 200
aged (172) 172
npm1 mutations (166) 166
normal karyotype (138) 138
leukemia (130) 130
cancer (128) 128
acute myeloid-leukemia (124) 124
fms-like tyrosine kinase 3 - genetics (122) 122
adolescent (117) 117
young adult (111) 111
internal tandem duplication (107) 107
favorable prognosis (106) 106
leukemia, myeloid, acute - diagnosis (106) 106
leukemia, myeloid, acute - pathology (100) 100
nucleophosmin npm1 (100) 100
gene-mutations (98) 98
aged, 80 and over (96) 96
nucleophosmin (95) 95
minimal residual disease (90) 90
leukemia, myeloid, acute - mortality (89) 89
flt3 (85) 85
hemic and lymphatic diseases (82) 82
analysis (81) 81
genetic aspects (79) 79
nuclear proteins - metabolism (74) 74
normal cytogenetics (73) 73
cytogenetics (72) 72
expression (72) 72
adult patients (71) 71
gene mutations (71) 71
mutations (71) 71
npm1 mutation (71) 71
chemotherapy (67) 67
leukemia, myeloid, acute - metabolism (66) 66
leukemia, myeloid, acute - therapy (63) 63
flt3-itd (62) 62
prognostic-significance (60) 60
gene expression (59) 59
leukemia, myeloid, acute - drug therapy (59) 59
research (58) 58
cytoplasmic nucleophosmin (56) 56
animals (52) 52
retrospective studies (52) 52
pathology (50) 50
younger adults (49) 49
myeloid leukemia (48) 48
treatment outcome (48) 48
disease-free survival (47) 47
gene (47) 47
karyotyping (47) 47
mutation - genetics (47) 47
genes (45) 45
medicine & public health (45) 45
stem cells (45) 45
impact (44) 44
transplantation (44) 44
prognostic impact (43) 43
dna mutational analysis (42) 42
flow cytometry (42) 42
acute promyelocytic leukemia (40) 40
child (40) 40
group-b (40) 40
biochemistry & molecular biology (39) 39
health aspects (39) 39
polymerase chain reaction (39) 39
abridged index medicus (38) 38
biomarkers, tumor - genetics (38) 38
medical prognosis (37) 37
proteins (37) 37
recurrence (37) 37
risk factors (37) 37
article (36) 36
genetic research (35) 35
hematology, oncology and palliative medicine (35) 35
patients (35) 35
remission induction (35) 35
survival (35) 35
survival rate (35) 35
classification (34) 34
npmc aml (34) 34
survival analysis (34) 34
relapse (33) 33
bone marrow (32) 32
myelodysplastic syndromes (32) 32
cell biology (31) 31
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (634) 634
Russian (4) 4
Chinese (3) 3
French (3) 3
German (3) 3
Japanese (2) 2
Turkish (2) 2
Czech (1) 1
Persian (1) 1
Polish (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Clinical Pathology, ISSN 0002-9173, 07/2015, Volume 144, Issue 1, pp. 29 - 43
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 07/2019, Volume 514, Issue 4, pp. 1278 - 1284
Our previous study reported that cancer upregulated gene (CUG)2, a novel oncogene, induces both faster cell migration and anti-cancer drug resistance. We thus... 
Cancer stem cell | Stemness | TGF-β | CUG2 | NPM1
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2008, Volume 105, Issue 10, pp. 3945 - 3950
Journal Article
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, ISSN 0253-2727, 11/2017, Volume 38, Issue 11, pp. 940 - 944
Journal Article
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, ISSN 0390-6078, 10/2011, Volume 96, Issue 10, pp. 1568 - 1570
Journal Article
Journal of Immunology, ISSN 0022-1767, 2019, Volume 202, Issue 6, pp. 1885 - 1894
Development of targeted cancer therapy requires a thorough understanding of mechanisms of tumorigenesis as well as mechanisms of action of therapeutics. This... 
MUTANT NUCLEOPHOSMIN | AML | CYTOPLASMIC NUCLEOPHOSMIN | CELLS | GENE | ACUTE MYELOGENOUS LEUKEMIA | DISTINCT | NUCLEOPHOSMIN NPM1 | MUTATIONS | IMMUNOLOGY | EXPRESSION
Journal Article
British Journal of Haematology, ISSN 0007-1048, 2/2016, Volume 172, Issue 4, pp. 573 - 580
Older adult patients (≥60 years) with acute myeloid leukaemia ( AML ) are generally considered to be poor‐risk and there is limited information available... 
molecular prognostication | CEBPA genotype | Research Paper | Haematological Malignancy | acute myeloid leukaemia | NPM1 and FLT3 genotype
Journal Article
Leukemia, ISSN 0887-6924, 07/2018, Volume 32, Issue 7, pp. 1479 - 1481
Journal Article
Journal Article
BBA - General Subjects, ISSN 0304-4165, 08/2018, Volume 1862, Issue 8, pp. 1729 - 1741
p300 (KAT3B) lysine acetyltransferase activity is modulated under different physiological and pathological contexts through the induction of -autoacetylation.... 
p300 chaperone | Oral cancer | Small molecule inhibitor of NPM1 oligomerization | Histone hyperacetylation | trans-Autoacetylation | PROTEIN | CHROMATIN | ACETYLATION | Small molecule inhibitor of NPM1 | P300 | BIOCHEMISTRY & MOLECULAR BIOLOGY | CATALYTIC CORE | CANCER | CBP | BIOPHYSICS | oligomerization | HUMAN NUCLEOPHOSMIN | GROWTH | BINDING | Oligomers | Analysis | Restaurants
Journal Article
Cancers, ISSN 2072-6694, 09/2019, Volume 11, Issue 10, p. 1455
We analyzed the impact of alloHSCT in a single center cohort of 89 newly diagnosed NPM1mut AML patients, consecutively treated according to the Northern Italy... 
acute myeloid leukemia | allogeneic stem cell transplantation | nucleophosmin (NPM1)
Journal Article
BLOOD, ISSN 0006-4971, 06/2019, Volume 133, Issue 25, pp. 2682 - 2695
This study was performed to assess the utility of tumor-derived fragmentary DNA, or circulating tumor DNA (ctDNA), for identifying high-risk patients for... 
RELAPSE | NPM1 | MANAGEMENT | STANDARD-RISK | ACUTE MYELOID-LEUKEMIA | LIQUID BIOPSIES | FLOW-CYTOMETRY | OUTCOMES | HEMATOLOGY | MINIMAL RESIDUAL DISEASE | REMISSION
Journal Article